Knowledge Management System of Institute of Zoology, CAS
First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells | |
Source Publication | CELL PROLIFERATION
![]() |
2020 | |
Volume | 53Issue:12Pages:e12943 |
Wu J(吴骏); Hu Zhongjie; Wang L(王柳); Tan YQ(谭元卿); Hou Wei; Li ZW(李仲文); Gao TT(高婷婷); Fan JQ(范佳琪); Guo BJ(郭保杰); Dai Huaping; Li W(李伟); Hao J(郝捷); Jin Ronghua; Hu BY(胡宝洋) | |
Document Type | 期刊论文 |
Identifier | http://ir.ioz.ac.cn/handle/000000/14489 |
Collection | 干细胞与生殖生物学国家重点实验室 |
Recommended Citation GB/T 7714 | Wu J,Hu Zhongjie,Wang L,et al. First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells[J]. CELL PROLIFERATION,2020,53(12):e12943. |
APA | 吴骏.,Hu Zhongjie.,王柳.,谭元卿.,Hou Wei.,...&胡宝洋.(2020).First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells.CELL PROLIFERATION,53(12),e12943. |
MLA | 吴骏,et al."First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells".CELL PROLIFERATION 53.12(2020):e12943. |
Files in This Item: | ||||||
File Name/Size | DocType | Version | Access | License | ||
First case of COVID-(469KB) | 期刊论文 | 出版稿 | 开放获取 | CC BY-NC-SA | View Application Full Text |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment